JP2025517106A5 - - Google Patents
Info
- Publication number
- JP2025517106A5 JP2025517106A5 JP2024563976A JP2024563976A JP2025517106A5 JP 2025517106 A5 JP2025517106 A5 JP 2025517106A5 JP 2024563976 A JP2024563976 A JP 2024563976A JP 2024563976 A JP2024563976 A JP 2024563976A JP 2025517106 A5 JP2025517106 A5 JP 2025517106A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/089986 | 2022-04-28 | ||
| CN2022089986 | 2022-04-28 | ||
| PCT/CN2023/077272 WO2023207283A1 (en) | 2022-04-28 | 2023-02-20 | Compounds as parp1 inhibitiors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025517106A JP2025517106A (ja) | 2025-06-03 |
| JPWO2023207283A5 JPWO2023207283A5 (https=) | 2026-02-27 |
| JP2025517106A5 true JP2025517106A5 (https=) | 2026-02-27 |
Family
ID=88517229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563976A Pending JP2025517106A (ja) | 2022-04-28 | 2023-02-20 | Ｐａｒｐ１阻害剤としての化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250289814A1 (https=) |
| EP (1) | EP4514795A4 (https=) |
| JP (1) | JP2025517106A (https=) |
| KR (1) | KR20250033148A (https=) |
| CN (1) | CN119487027A (https=) |
| WO (1) | WO2023207283A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023209820B2 (en) | 2022-01-21 | 2024-10-10 | Xinthera, Inc. | Parp1 inhibitors and uses thereof |
| KR20240161147A (ko) | 2022-03-14 | 2024-11-12 | 슬랩 파마슈티컬스 엘엘씨 | 다중 사이클릭 화합물 |
| FI4497438T3 (fi) | 2022-04-28 | 2025-10-20 | Xinthera Inc | Trisyklisiä parp1:n estäjiä ja niiden käyttötapoja |
| TW202416977A (zh) * | 2022-09-30 | 2024-05-01 | 大陸商中國醫藥研究開發中心有限公司 | 含氮雜環類化合物及其醫藥用途 |
| US20250129051A1 (en) * | 2023-10-23 | 2025-04-24 | Gilead Sciences, Inc. | Parp1 inhibitors and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9903758A3 (en) * | 1996-05-29 | 2000-07-28 | Warner Lambert Co | Benzoxazinone dopamine d4 receptor antagonists and pharmaceutical compositions containing the same |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| RU2007101544A (ru) * | 2004-06-17 | 2008-08-10 | Уайт (Us) | Антагонисты рецепторов высвобождающего гонадотропин гормона |
| US8404713B2 (en) * | 2007-10-26 | 2013-03-26 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP inhibitors |
| AR070221A1 (es) * | 2008-01-23 | 2010-03-25 | Astrazeneca Ab | Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas. |
| WO2010111626A2 (en) * | 2009-03-27 | 2010-09-30 | Takeda Pharmaceutical Company Limited | Poly (adp-ribose) polymerase (parp) inhibitors |
| MX2022000711A (es) * | 2019-07-19 | 2022-02-23 | Astrazeneca Ab | Inhibidores de parp1. |
| TW202309025A (zh) * | 2021-04-19 | 2023-03-01 | 美商辛瑟拉股份有限公司 | Parp1抑制劑及其用途 |
| WO2022228387A1 (en) * | 2021-04-26 | 2022-11-03 | Fochon Biosciences, Ltd. | Compounds as parp inhibitors |
| US20230159525A1 (en) * | 2021-10-01 | 2023-05-25 | Xinthera, Inc. | Azetidine and pyrrolidine parp1 inhibitors and uses thereof |
| TW202416977A (zh) * | 2022-09-30 | 2024-05-01 | 大陸商中國醫藥研究開發中心有限公司 | 含氮雜環類化合物及其醫藥用途 |
-
2023
- 2023-02-20 EP EP23794719.7A patent/EP4514795A4/en active Pending
- 2023-02-20 JP JP2024563976A patent/JP2025517106A/ja active Pending
- 2023-02-20 KR KR1020247039613A patent/KR20250033148A/ko active Pending
- 2023-02-20 WO PCT/CN2023/077272 patent/WO2023207283A1/en not_active Ceased
- 2023-02-20 CN CN202380050136.0A patent/CN119487027A/zh active Pending
- 2023-02-20 US US18/861,016 patent/US20250289814A1/en active Pending